A Study to Assess the Effect of Upadacitinib in Atopic Dermatitis-induced Sleep Disturbance in Adults With Moderate to Severe Atopic Dermatitis

Clinical trial NCT06390722 · WITHDRAWN

Trial details

NCT number: NCT06390722
Sponsor: AbbVie
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis Sleep Disturbance

Start date: 2024-05-23
Primary completion: 2026-01-05
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.